MedPath

Impact on body composition and Sugar metabolism and Lipid metabolism by Diet therapy of BCAA or EPA added diet to patients with obesity type 2 diabetes

Not Applicable
Conditions
obesity type 2 diabetes
Registration Number
JPRN-UMIN000023441
Lead Sponsor
The University of Tokyo Hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
20
Inclusion Criteria

Not provided

Exclusion Criteria

1.expectant and nursing mothers 2.ckd classification 3 period or more 3.cirrhosis of the liver 4.chronic pancreatitis (decompensated stage) 5.gastrointestinal disorders 6.there is a history of severe hypoglycemia 7.some of the heart pacemaker implantation 8.some of the contracture 9.if there is a taking of sglt2 inhibitors as drug therapy

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath